Trualt Bioenergy has approved fresh capital infusion totaling Rs 29.69 crore into its joint venture subsidiaries, Leafiniti Bioenergy and TruAlt Sumi Gas. The board also announced the appointment of Dr. Sarvamangala R Patil as a Non-Executive Independent Director, subject to shareholder approval via postal ballot. These investments aim to bolster the scaling efforts of its bioenergy units, particularly as the Japan-backed TruAlt Sumi Gas venture moves toward commercial operations.
Trualt Bioenergy Boosts Subsidiaries With Rs 29.69 Crore Investment
Trualt Bioenergy has sanctioned a total investment of Rs 29.69 crore across two key subsidiaries.
This capital infusion includes Rs 21.42 crore for Leafiniti Bioenergy and Rs 8.27 crore for TruAlt Sumi Gas.
Reader Takeaway: Continued capital support for bioenergy growth ventures while strengthening board governance with a new independent director.
What just happened
The board of Trualt Bioenergy approved an equity investment of Rs 21.42 crore in Leafiniti Bioenergy, a joint venture with GAIL India, by subscribing to 2.14 crore shares at par. Simultaneously, the company committed Rs 8.27 crore to TruAlt Sumi Gas, a joint venture with Japan’s Sumitomo Corporation, by purchasing 24.31 lakh shares at a premium price of Rs 34 per share. Additionally, the company appointed Dr. Sarvamangala R Patil as an Additional Director (Non-Executive Independent).
Why this matters
The financial support ensures these subsidiaries maintain adequate liquidity and capital for their respective business cycles. For Leafiniti Bioenergy, which recorded a turnover of Rs 40.43 crore in FY26, the funds support scaling existing operations. For TruAlt Sumi Gas, the capital is essential as the entity moves through its pre-operational phase toward future commercialization.
Governance and Board Update
The appointment of Dr. Sarvamangala R Patil reflects the company's commitment to compliance and board diversity. The company has initiated a postal ballot to formalize her tenure as an Independent Director for a one-year term concluding September 21, 2027.
What to track next
Investors should monitor the operational milestones of the TruAlt Sumi Gas joint venture, specifically the timeline for moving from the pre-operational stage to revenue generation. Furthermore, the outcome of the postal ballot regarding the board appointment will confirm the updated governance structure.